Thyroid Eye Disease (TED)
Endocrinology
2
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
Zai LabZL-1109
Kriya TherapeuticsVV-14305
Clinical Trials (2)
Total enrollment: 99 patients across 2 trials
A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease
Start: Dec 2025Est. completion: Jan 202899 patients
Phase 3Recruiting
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
Start: Feb 2026Est. completion: Feb 2029
Phase 1/2Not Yet Recruiting
Related Jobs in Endocrinology
Senior Scientist, Analytical Development
Neurocrine Biosciences
US CA San Diego
Yesterday
$111K - $151K/yr
Clinical Practice Liaison - Psych, Kansas
Neurocrine Biosciences
Kansas City, MO
Yesterday
$161K - $220K/yr
Medical Science Liaison/Sr. Medical Science Liaison
Neurocrine Biosciences
US NC Home Office
Yesterday
$161K - $220K/yr
Principal Scientist, Lead Generation Biology (Head of Biophysics/SPR Lab)
Neurocrine Biosciences
US CA San Diego
2d ago
$131K - $179K/yr
Long Term Care Account Specialist - Oceanside CA
Neurocrine Biosciences
Oceanside CA
2d ago
$123K - $168K/yr
Sr. Clinical Trials Manager
Neurocrine Biosciences
UK London
2d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 99 patients
2 companies competing in this space